Mercanis Secures Over $20 Million in Series A Round
Berlin, June 18, 2025 (GLOBE NEWSWIRE) -- The company receives fresh capital…
Draig Therapeutics Launches with $140 Million (107 Million) Total Investment to Advance its Portfolio of Next-Generation Therapies for Major Neuropsychiatric Disorders
Clinical-stage company led by world-class team targeting core neurotransmission pathways underlying neuropsychiatric…
Golfers swing into action for the Chilterns Neuro Centre
Wednesday 11 June, 2025 The Chilterns Neuro Centre is delighted by the…
